Valsartan Medication May Be Causing Drug-Induced Angioedema
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), were detected in the product—a…